FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Hydroxocobalamin Injection
Status: Currently in Shortage
»Date first posted: 04/20/2021
»Therapeutic Categories: Endocrinology/Metabolism; Other

Expand all

SERB SA (Revised 12/15/2021)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Hydroxocobalamin Injection (Cyanokit) intravenous powder for solution for injection, 5 gram, vial, (NDC 11704-0370-01) Available Product Is distributed by BTG International Inc.; Contact number: 1-844-293-0007. Other

Teva Pharmaceuticals (Reverified 01/18/2022)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Hydroxocobalamin Injection 1000MCG/ML, 1X30ML(NDC 0591-2888-30) Available Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English